Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po-Hong Liu

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Medicine|July 23, 2015
Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC SystemChia-Yang Hsu, Po-Hong Liu, Yun-Hsuan Lee, et al.
Cancers|September 9, 2022
Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden ScoreShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 30, 2014
Surgical resection is better than transarterial chemoembolization for hepatocellular carcinoma beyond Milan criteria independent of performance statusPo-Hong Liu, Yun-Hsuan Lee, Chia-Yang Hsu, et al.
Cancers|February 11, 2023
Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI GradeJia-I Liao, Shu-Yein Ho, Po-Hong Liu, et al.
Cancers|February 15, 2022
A New Tumor Burden Score and Albumin-Bilirubin Grade-Based Prognostic Model for Hepatocellular CarcinomaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Annals of Surgery|March 17, 2015
Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score ModelPo-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, et al.
International Journal of Molecular Sciences|December 9, 2023
Albumin-Based Liver Reserve Models vs. MELD 3.0 in Prognostic Prediction for Hepatocellular Carcinoma Patients with Renal InsufficiencyShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Annals of Surgical Oncology|October 22, 2015
Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram StudyChia-Yang Hsu, Po-Hong Liu, Cheng-Yuan Hsia, et al.
Journal of Gastroenterology and Hepatology|July 22, 2014
Impact of renal insufficiency on patients with hepatocellular carcinoma undergoing radiofrequency ablationChuan-Fu Chen, Po-Hong Liu, Yun-Hsuan Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 15, 2016
Nomogram of the Barcelona Clinic Liver Cancer system for individual prognostic prediction in hepatocellular carcinomaChia-Yang Hsu, Po-Hong Liu, Cheng-Yuan Hsia, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Medicine|July 23, 2015
Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC SystemChia-Yang Hsu, Po-Hong Liu, Yun-Hsuan Lee, et al.
Cancers|September 9, 2022
Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden ScoreShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 30, 2014
Surgical resection is better than transarterial chemoembolization for hepatocellular carcinoma beyond Milan criteria independent of performance statusPo-Hong Liu, Yun-Hsuan Lee, Chia-Yang Hsu, et al.
Cancers|February 11, 2023
Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI GradeJia-I Liao, Shu-Yein Ho, Po-Hong Liu, et al.
Cancers|February 15, 2022
A New Tumor Burden Score and Albumin-Bilirubin Grade-Based Prognostic Model for Hepatocellular CarcinomaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Annals of Surgery|March 17, 2015
Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score ModelPo-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, et al.
International Journal of Molecular Sciences|December 9, 2023
Albumin-Based Liver Reserve Models vs. MELD 3.0 in Prognostic Prediction for Hepatocellular Carcinoma Patients with Renal InsufficiencyShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Annals of Surgical Oncology|October 22, 2015
Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram StudyChia-Yang Hsu, Po-Hong Liu, Cheng-Yuan Hsia, et al.
Journal of Gastroenterology and Hepatology|July 22, 2014
Impact of renal insufficiency on patients with hepatocellular carcinoma undergoing radiofrequency ablationChuan-Fu Chen, Po-Hong Liu, Yun-Hsuan Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 15, 2016
Nomogram of the Barcelona Clinic Liver Cancer system for individual prognostic prediction in hepatocellular carcinomaChia-Yang Hsu, Po-Hong Liu, Cheng-Yuan Hsia, et al.
Pageof 9